Literature DB >> 7956452

Antibiotic resistance patterns of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis: a prospective study in Murcia, Spain, 1983-1992.

J Gómez1, J Ruiz-Gómez, J L Hernández-Cardona, M L Núñez, M Canteras, M Valdés.   

Abstract

We prospectively determined the role of commonly used antibiotics in the emergence of antimicrobial resistance among the predominant pathogens associated with the respiratory tract. Clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis from otic exudates, exudates obtained by puncture of the paranasal sinuses, sputum samples or blood cultures obtained from hospital inpatients with symptoms of significant upper or lower respiratory tract infection were analyzed. Between 1983 and 1992 a statistically significant increase in strains of S. pneumoniae and H. influenzae resistant to ampicillin, erythromycin and co-trimoxazole was detected. A significant increase in strains of M. catarrhalis resistant to ampicillin was also found. The increase in the consumption of aminopenicillins, co-trimoxazole and macrolides was associated with an increase in strains of S. pneumoniae, H. influenzae and M. catarrhalis resistant to these agents.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7956452     DOI: 10.1159/000239210

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  9 in total

1.  influence of TEM-1 beta-lactamase on the pharmacodynamic activity of simulated total versus free-drug serum concentrations of cefditoren (400 milligrams) versus amoxicillin-clavulanic acid (2,000/125 milligrams) against Haemophilus influenzae strains exhibiting an N526K mutation in the ftsI gene.

Authors:  M Torrico; L Aguilar; N González; M J Giménez; O Echeverría; F Cafini; D Sevillano; L Alou; P Coronel; J Prieto
Journal:  Antimicrob Agents Chemother       Date:  2007-07-30       Impact factor: 5.191

2.  Prospective study of epidemiology and prognostic factors in community-acquired pneumonia.

Authors:  J Gómez; V Baños; J Ruiz Gómez; M C Soto; L Muñoz; M L Nuñez; M Canteras; M Valdés
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-07       Impact factor: 3.267

3.  Molecular epidemiology of penicillin-resistant Streptococcus pneumoniae isolates recovered in Italy from 1993 to 1996.

Authors:  A Marchese; M Ramirez; G C Schito; A Tomasz
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

4.  Multidrug-resistant Streptococcus pneumoniae in Poland: identification of emerging clones.

Authors:  K Overweg; P W Hermans; K Trzcinski; M Sluijter; R de Groot; W Hryniewicz
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

5.  mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae.

Authors:  A Tait-Kamradt; J Clancy; M Cronan; F Dib-Hajj; L Wondrack; W Yuan; J Sutcliffe
Journal:  Antimicrob Agents Chemother       Date:  1997-10       Impact factor: 5.191

Review 6.  Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases.

Authors:  K McGregor; B J Chang; B J Mee; T V Riley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-04       Impact factor: 3.267

Review 7.  Cefditoren in upper and lower community-acquired respiratory tract infections.

Authors:  Francisco Soriano; María-José Giménez; Lorenzo Aguilar
Journal:  Drug Des Devel Ther       Date:  2011-02-09       Impact factor: 4.162

8.  Drug resistance in community-acquired respiratory tract infections: role for an emerging antibacterial.

Authors:  Lorenzo Aguilar; María-José Giménez; José Barberán
Journal:  Infect Drug Resist       Date:  2010-06-18       Impact factor: 4.003

9.  Bacteria from bronchoalveolar lavage fluid from children with suspected chronic lower respiratory tract infection: results from a multi-center, cross-sectional study in Spain.

Authors:  Amparo Escribano Montaner; Juan García de Lomas; José Ramón Villa Asensi; Oscar Asensio de la Cruz; Olga de la Serna Blázquez; Mikel Santiago Burruchaga; Pedro Mondéjar López; Alba Torrent Vernetta; Yang Feng; Melissa K Van Dyke; Janet Reyes; Pilar Garcia-Corbeira; Carla A Talarico
Journal:  Eur J Pediatr       Date:  2017-12-29       Impact factor: 3.183

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.